Comparison of the transgenic rodent mutation assay, error corrected next generation duplex sequencing, and the alkaline comet assay to detect dose-related mutations following exposure to N-nitrosodiethylamineJoel P. Bercu, Maik Schuler, Shaofei Zhang et al.|Mutation Research/Genetic Toxicology and Environmental Mutagenesis|2023Cited by 34
Qualification of impurities based on metabolite dataLars Weidolf, Bruce A. Trela, Martin A. Hayes et al.|Regulatory Toxicology and Pharmacology|2019Cited by 20
N-Nitrosamine drug substance related impurities (NDSRIs) – A proposal for the addition of subcategories to carcinogenic potency categorization approach categories 1 and 2 for NDSRIs with a molecular weight > 200 DaJoel P. Bercu, Mike W Urquhart, Olivier Dirat et al.|Regulatory Toxicology and Pharmacology|2024Cited by 14
Evaluating the lifetime cumulative dose as a basis for carcinogenic potency of nitrosamines – a key tenet underpinning less-than-lifetime approaches for establishing acceptable intake limitsSusan P. Felter, Joel P. Bercu, Ashley M Mudd et al.|Regulatory Toxicology and Pharmacology|2025Cited by 5
Ames concordance with the in vivo transgenic rodent (TGR) gene mutation assay for NDSRIs and relative in vivo TGR potency with nitrosamines with robust dose-response carcinogenicity dataRobert A. Jolly, Raechel Puglisi, Alejandra Trejo-Martin et al.|Regulatory Toxicology and Pharmacology|2026Cited by 3